1. Home
  2. SGMO

SGMO

Sangamo Therapeutics Inc.

Logo Sangamo Therapeutics Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-24-2024 2:57pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Founded: 1995 Country:
N/A
Employees: N/A City: RICHMOND
Market Cap: 105.8M IPO Year: 2000
Target Price: $4.64 AVG Volume (30 days): 2.4M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.48 EPS Growth: N/A
52 Week Low/High: $0.29 - $1.81 Next Earning Date: 01-01-0001
Revenue: $176,232,000 Revenue Growth: 58.34%
Revenue Growth (this year): -73.45% Revenue Growth (next year): 72.21%

Share on Social Networks: